{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:20:37Z","timestamp":1792243237621,"version":"4.4.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prurigo nodularis (PN) is a debilitating skin condition. When inadequate disease control is achieved or other systemic therapies are contraindicated, Janus kinase inhibitors (JAKis) may be considered, although real-world evidence remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate clinical findings and treatment outcomes among patients diagnosed with PN and treated with JAKis in a real-world setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort study across 23 Italian tertiary referral hospitals. Patients with PN were eligible if aged \u2265 18\u2005years and had received a JAKi with a minimum follow-up of 12 weeks. The primary outcome was defined as the proportion of patients achieving a reduction of \u2265 4 points from baseline in the Peak Pruritus Numerical Rating Scale score. Key secondary outcomes included the rates of patients reaching a significant reduction in Investigator Global Assessment of Prurigo Nodularis Stage (IGA PN-S) and Investigator Global Assessment of Prurigo Nodularis Activity (IGA PN-A) scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the total, 71 patients met the inclusion criteria. At week 16, the proportion of patients achieving the primary outcome was 94% for upadacitinib [n = 52\/55; 95% confidence interval (CI) 87\u2013100%], 83% for abrocitinib (n = 10\/12; 95% CI 52\u201398%) and 100% for baricitinib (n = 4\/4; 95% CI 40\u2013100%), with results sustained at week 24. An IGA PN-A score of 0\/1 was achieved in 90% of patients treated with upadacitinib and abrocitinib and in 50% of those on baricitinib by week 24. Improvements were observed across all other secondary outcomes assessed, with no safety concerns reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study suggests that JAKis can achieve clinically meaningful outcomes in PN irrespective of atopic background, supporting their use across diverse patient profiles. Further research is warranted to validate these observations and explore their long-term effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llaf302","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:35:41Z","timestamp":1751960141000},"page":"2211-2220","source":"Crossref","is-referenced-by-count":5,"title":["Therapeutic outcomes across Janus kinase inhibitors in\u00a0prurigo nodularis"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-2370","authenticated-orcid":false,"given":"Gianluca","family":"Avallone","sequence":"first","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]},{"name":"Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4173-0282","authenticated-orcid":false,"given":"Andrea","family":"Bombelli","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]},{"name":"Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6479-0986","authenticated-orcid":false,"given":"Luca","family":"Valtellini","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]},{"name":"Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-318X","authenticated-orcid":false,"given":"Gianluca","family":"Tavoletti","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]},{"name":"Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Maurelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6051-1676","authenticated-orcid":false,"given":"Luigi","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Narcisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"di Vico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Caccavale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Balato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7188-7310","authenticated-orcid":false,"given":"Francesca","family":"Barei","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calzari","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Trave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Cozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rongioletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sveva","family":"Lenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Gurioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eustachio","family":"Nettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Caroppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Errichetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bonzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketty","family":"Peris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Del Regno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Savoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Esposto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cataldo","family":"Patruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pezzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7919-8141","authenticated-orcid":false,"given":"Luca","family":"Stingeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mastorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Ortoncelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ribero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo V","family":"Marzano","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]},{"name":"Department of Pathophysiology and Transplantation, Universit\u00e0 degli Studi di Milano , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia M","family":"Ferrucci","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"2025102707121202600_llaf302-B1","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jaad.2020.04.183","article-title":"Prurigo nodularis: epidemiology and clinical features","volume":"83","author":"Huang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025102707121202600_llaf302-B2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/ced.14722","article-title":"Clinical characteristics and disease burden in prurigo nodularis","volume":"46","author":"Aggarwal","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"2025102707121202600_llaf302-B3","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1111\/bjd.21843","article-title":"Prurigo nodularis: the epidemiology of an under-recognized disease","volume":"187","author":"Froelunde","year":"2022","journal-title":"Br J Dermatol"},{"key":"2025102707121202600_llaf302-B4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40257-023-00818-z","article-title":"Chronic prurigo including prurigo nodularis: new insights and treatments","volume":"25","author":"M\u00fcller","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"2025102707121202600_llaf302-B5","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jaad.2020.04.182","article-title":"Prurigo nodularis: pathogenesis and management","volume":"83","author":"Williams","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025102707121202600_llaf302-B6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaad.2020.07.025","article-title":"Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus","volume":"84","author":"Elmariah","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2025102707121202600_llaf302-B7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/17512433.2021.1852080","article-title":"Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis","volume":"14","author":"Williams","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025102707121202600_llaf302-B8","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41591-023-02320-9","article-title":"Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials","volume":"29","author":"Yosipovitch","year":"2023","journal-title":"Nat Med"},{"key":"2025102707121202600_llaf302-B9","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa2301333","article-title":"Phase 3 trial of nemolizumab in patients with prurigo nodularis","volume":"389","author":"Kwatra","year":"2023","journal-title":"N Engl J Med"},{"key":"2025102707121202600_llaf302-B10","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1080\/09546634.2021.1886232","article-title":"Dupilumab as promising treatment for prurigo nodularis: current evidences","volume":"33","author":"Toffoli","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2025102707121202600_llaf302-B11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJMoa1908316","article-title":"Trial of nemolizumab in moderate-to-severe prurigo nodularis","volume":"382","author":"St\u00e4nder","year":"2020","journal-title":"N Engl J Med"},{"key":"2025102707121202600_llaf302-B12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jdin.2024.03.025","article-title":"Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)","volume":"16","author":"Yosipovitch","year":"2024","journal-title":"JAAD Int"},{"key":"2025102707121202600_llaf302-B13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/bjd\/ljae131","article-title":"Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II\/III clinical study in patients aged \u2265 13\u2005years","volume":"191","author":"Yokozeki","year":"2024","journal-title":"Br J Dermatol"},{"key":"2025102707121202600_llaf302-B14","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/bjd\/ljae052","article-title":"Prurigo nodularis: new insights into pathogenesis and novel therapeutics","volume":"190","author":"Liao","year":"2024","journal-title":"Br J Dermatol"},{"key":"2025102707121202600_llaf302-B15","doi-asserted-by":"crossref","first-page":"1301817","DOI":"10.3389\/fimmu.2023.1301817","article-title":"Molecular mechanisms of pruritus in prurigo nodularis","volume":"14","author":"Shao","year":"2023","journal-title":"Front Immunol"},{"key":"2025102707121202600_llaf302-B16","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/ced\/llae329","article-title":"Successful treatment of prurigo nodularis with upadacitinib","volume":"50","author":"Avallone","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"2025102707121202600_llaf302-B17","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/jdv.19462","article-title":"Treatment of chronic prurigo with upadacitinib: a case series","volume":"38","author":"Gil-Lianes","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025102707121202600_llaf302-B18","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1111\/jdv.17991","article-title":"Improvement of chronic nodular prurigo with baricitinib","volume":"36","author":"Pereira","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025102707121202600_llaf302-B19","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jaad.2024.06.094","article-title":"Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: a multicenter case series study","volume":"91","author":"Pezzolo","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2025102707121202600_llaf302-B20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4168\/aair.2024.16.5.546","article-title":"Treatment with upadacitinib in refractory prurigo nodularis: a prospective cohort study","volume":"16","author":"Lee","year":"2024","journal-title":"Allergy Asthma Immunol Res"},{"key":"2025102707121202600_llaf302-B21","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1111\/jdv.20322","article-title":"Abrocitinib for prurigo nodularis: clinical efficacy and safety profile","volume":"39","author":"Wang","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025102707121202600_llaf302-B22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/derm.2022.0065","article-title":"Failure of dupilimab with severe prurigo nodularis that responded well to abrocitinib","volume":"34","author":"Vander Does","year":"2023","journal-title":"Dermatitis"},{"key":"2025102707121202600_llaf302-B23","doi-asserted-by":"crossref","first-page":"e15642","DOI":"10.1111\/dth.15642","article-title":"Successful treatment of refractory prurigo nodularis with baricitinib","volume":"35","author":"Yin","year":"2022","journal-title":"Dermatol Ther"},{"key":"2025102707121202600_llaf302-B24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"2025102707121202600_llaf302-B25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jaci.2016.12.960","article-title":"Janus kinase inhibitors display broad anti-itch properties: a possible link through the TRPV1 receptor","volume":"140","author":"Fukuyama","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2025102707121202600_llaf302-B26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jamadermatol.2024.1464","article-title":"Efficacy and safety of abrocitinib in prurigo nodularis and chronic pruritus of unknown origin: a nonrandomized controlled trial","volume":"160","author":"Kwatra","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2025102707121202600_llaf302-B27","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/all.16478","article-title":"Effectiveness and safety of dupilumab for prurigo nodularis in China: a multicentric and observational study","volume":"80","author":"Zhao","year":"2025","journal-title":"Allergy"},{"key":"2025102707121202600_llaf302-B28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaad.2020.03.049","article-title":"Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo","volume":"83","author":"Chiricozzi","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2025102707121202600_llaf302-B29","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/jcm13030878","article-title":"Dupilumab for treatment of prurigo nodularis: real-life effectiveness for up to 84 weeks","volume":"13","author":"Paganini","year":"2024","journal-title":"J Clin Med"},{"key":"2025102707121202600_llaf302-B30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13555-023-00892-5","article-title":"A review on the safety of using JAK inhibitors in dermatology: clinical and laboratory monitoring","volume":"13","author":"Samuel","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2025102707121202600_llaf302-B31","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaad.2024.01.004","article-title":"Clinical outcomes and management of JAK inhibitor-associated acne in patients with moderate-to-severe atopic dermatitis undergoing upadacitinib: a multicenter retrospective study","volume":"90","author":"Avallone","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"2025102707121202600_llaf302-B32","doi-asserted-by":"crossref","first-page":"101826","DOI":"10.1016\/j.eclinm.2023.101826","article-title":"Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor \u03b2 antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study","volume":"57","author":"Sofen","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025102707121202600_llaf302-B33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/ijd.17493","article-title":"Association between atopic dermatitis and prurigo nodularis: a systematic review and meta-analysis","volume":"64","author":"Li","year":"2025","journal-title":"Int J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf302\/63772165\/llaf302.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/11\/2211\/63772165\/llaf302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/11\/2211\/63772165\/llaf302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:12:24Z","timestamp":1761563544000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/11\/2211\/8203001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,7,16]]},"published-print":{"date-parts":[[2025,10,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf302","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,7,16]]}}}